Skip to content

CDR

Executive leadership changes at Kimberly-Clark

Executive leadership changes at Kimberly-Clark

Kimberly-Clark  announced executive leadership changes to sharpen its focus on executing its global business plan. Kim Underhill, president of Kimberly-Clark Professional, has been named group president Kimberly-Clark North America.

Albertsons appoints senior VP

Albertsons appoints senior VP

Albertsons Cos. has promoted Sean Barrett to senior vice president of advertising and marketing. Barrett has been at Albertsons since 2015. At the time of his promotion, he was serving on the retailer’s own brands team as group vice president of innovation, product and brands.

CVS buys 14-store Red Cross Pharmacy

CVS buys 14-store Red Cross Pharmacy

Marshall, Mo.-based Red Cross Pharmacy Inc. plans to sell its retail pharmacies to CVS Pharmacy, both companies announced last month. Red Cross Pharmacy is a top-50 drug store chain and one of the oldest pharmacy businesses in the country.

Women executives form industry group

Women executives form industry group

A group of 19 high-profile women in the retail and health care industries formally announced the creation of an organization called WE during a reception at the National Association of Chain Drug Stores Annual Meeting here last month. The mission of WE, derived from the first two letters in well, is

MinuteClinic gets new exec

MinuteClinic gets new exec

CVS Health last month named Dr. Marc-David Munk as the new chief medical officer of MinuteClinic, the company’s retail medical clinic subsidiary, as well as associate chief medical officer of CVS Health.

Novartis announces FDA approval of Gilenya

Novartis announces FDA approval of Gilenya

Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.

Metro completes Coutu acquisition

Metro completes Coutu acquisition

Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than  1,300 stores in Quebec, Ontario and New Brunswick.

PANTHERx selected by Otsuka to distribute Jynarque

PANTHERx selected by Otsuka to distribute Jynarque

PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc.  to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).